Skip to main navigation
Skip to search
Skip to main content
University of Dundee Discovery Portal Home
Search content at University of Dundee Discovery Portal
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Metformin: still the sweet spot for CV protection in diabetes?
Graham Rena
(Lead / Corresponding author)
,
Ify Mordi
(Lead / Corresponding author)
,
Chim Lang
(Lead / Corresponding author)
Research output
:
Contribution to journal
›
Review article
›
peer-review
14
Link opens in a new tab
Citations (Scopus)
320
Downloads (Pure)
Overview
Fingerprint
Projects
(1)
Research Outputs
(1)
Activity
(1)
Press/Media
(1)
Fingerprint
Dive into the research topics of 'Metformin: still the sweet spot for CV protection in diabetes?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Diabetes
100%
Sweet
100%
Metformin
100%
Type 2 Diabetes Mellitus (T2DM)
75%
Metformin Use
50%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
50%
GLP-1 Receptor Agonist
50%
Randomized Controlled Trial
25%
Observational Data
25%
Drug Treatment
25%
Recent Changes
25%
New Drugs
25%
Mortality Rate
25%
Low Mortality
25%
Insulin
25%
Drug Combination
25%
Sulfonylurea
25%
Cardioprotection
25%
Patient Demographics
25%
Hemoglobin A1c (HbA1c)
25%
Clinical Experience
25%
Safety Data
25%
American Diabetes Association
25%
Specific Patient
25%
Clinical Trial Data
25%
European Society of Cardiology Guidelines
25%
Pharmacotherapy
25%
Diabetes Drugs
25%
Electronic Health Records
25%
Cardiovascular Outcome Trials
25%
First-line Drugs
25%
Atherosclerotic Cardiovascular Disease (ASCVD)
25%
Real-world Trials
25%
UK Prospective Diabetes Study (UKPDS)
25%
Medicine and Dentistry
Diabetes
100%
Glycon
100%
Maturity Onset Diabetes of the Young
50%
Receptor
33%
Drug Therapy
33%
Sodium Glucose Cotransporter 2 Inhibitor
33%
Randomized Controlled Trial
16%
Clinical Trial
16%
Mortality Rate
16%
Base
16%
Cardiovascular System
16%
Health Care Cost
16%
Sulfonylurea
16%
Hemoglobin A1c
16%
Cardiology
16%
Patient Population
16%
Drug Choice
16%
Electronic Health Record
16%
Pharmacology, Toxicology and Pharmaceutical Science
Metformin
100%
Non Insulin Dependent Diabetes Mellitus
50%
Pharmacotherapy
33%
Receptor Agonist
33%
Sodium Glucose Cotransporter 2 Inhibitor
33%
Clinical Trial
16%
Base
16%
Sulfonylurea
16%
Randomized Controlled Trial
16%
Mortality Rate
16%
Hemoglobin A1c
16%
Drug Choice
16%
Coronary Artery Atherosclerosis
16%